Clinical Pathway for Evaluation and Treatment of Children With Active COVID-19 Infection

• 2025

  Sign in to bookmark this resource.

  Sign in
• Katie Chiotos; Daniela Davis; Caryn Kerman; Jeffrey Gerber; Jane Lavelle

---

Access Resources

• Job AidEN
• Ask aRCie About This Resource

About

This webpage features a flowchart that outlines a clinical pathway for treating children with active COVID-19. It describes symptoms, isolation precautions, and treatment options like Paxlovid™ and Remdesivir. The text also covers guidelines for returning to sports after COVID-19, focusing on heart health concerns such as myocarditis. It includes recommendations for cardiac evaluations based on symptoms rather than routine tests. Special care is advised for severe cases requiring ICU admission. It emphasizes safety measures during ECMO procedures and provides links to additional resources from the Children's Hospital of Philadelphia (CHOP).

---

Tags

Focus Area: Infectious Disease

Audiences: Nurses; Physicians

Emergency Management Stage: Response

Keywords: Antiviral Agents; Myocarditis; Pediatrics; Critical Pathways; COVID-19

Institutions: Children's Hospital of Philadelphia

---

More like this

News & Views: Nirsevimab Means Brushing Up on Passive Immunity Talking Points 2023 · Children's Hospital of Philadelphia Emergency Department and Inpatient Clinical Pathway for Healthy Children with Dehydration from Gastroenteritis or Other Acute Illness 2025 · Children's Hospital of Philadelphia Emergency Department, PICU, and Inpatient Clinical Pathway for Infants > 28 Days and Children with Suspected Sepsis, Sepsis and Septic Shock 2024 · Children's Hospital of Philadelphia

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---